Document:

2005 Amended and Restated Stock Option Plan

 Exhibit 10.8 

NEOGENIX ONCOLOGY, INC. 

2005 AMENDED AND RESTATED STOCK OPTION PLAN 
  

	1.	DEFINITIONS. 

 Unless
otherwise specified or unless the context otherwise requires, the following terms, as used in this Neogenix Oncology, Inc. 2005 Amended and Restated Stock Option Plan, have the following meanings: 

“Affiliate” means a corporation which, for purposes of Section 424 of the Code, is a parent or subsidiary of the
Company, direct or indirect. 
 “Board of Directors” means the Board of Directors of the Company. 

“Change in Control” means the first to occur of the following: 

(1) the acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the
Exchange Act) (a “Person”) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (i) the then-outstanding shares of common stock of the Company (the “Outstanding
Company Common Stock”) or (ii) the combined voting power of the then-outstanding voting securities of the Company entitled to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided,
however, that, for purposes of this definition, the following acquisitions shall not constitute a Change in Control: (A) any acquisition directly from the Company, (B) any acquisition by the Company, (C) any acquisition by any
employee benefit plan (or related trust) sponsored or maintained by the Company or one of its affiliates, or (D) any acquisition pursuant to a transaction that complies with (3)(i), (3)(ii) and (3)(iii) below; 

(2) individuals who, as of the date hereof, constitute the Board of Directors (the “Incumbent Board”) cease for
any reason to constitute at least a majority of the Board of Directors; provided, however, that any individual becoming a director subsequent to the date hereof whose election or nomination for election by the Company’s stockholders was
approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial
assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the
Board of Directors; or 

 (3) consummation of a reorganization, merger, statutory share exchange or
consolidation or similar corporate transaction involving the Company or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of the Company, or the acquisition of assets or stock of another entity by the
Company or any of its subsidiaries (each, a “Business Combination”), in each case, unless, following such Business Combination, (i) all or substantially all of the individuals and entities that were the beneficial owners of the
Outstanding Company Common Stock and the Outstanding Company Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock and the combined
voting power of the then-outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation or entity resulting from such Business Combination (including, without limitation, a corporation
or entity that, as a result of such transaction, owns the Company or all or substantially all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately
prior to such Business Combination of the Outstanding Company Common Stock and the Outstanding Company Voting Securities, as the case may be, (ii) no Person (excluding any employee benefit plan (or related trust) of the Company or any
corporation or entity resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation or entity resulting from such Business
Combination or the combined voting power of the then-outstanding voting securities of such corporation or entity, except to the extent that such ownership existed prior to the Business Combination, and (iii) at least a majority of the members
of the board of directors of the corporation or entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board of Directors providing for such
Business Combination. 
 “Code” means the United States Internal Revenue Code of 1986, as amended. 

“Committee” means the Compensation Committee of the Board of Directors to which the Board of Directors has delegated
power to act under or pursuant to the provisions of the Plan. 
 “Common Stock” means shares of the
Company’s common stock, $0.00001 par value per share. 
 “Company” means Neogenix Oncology, Inc., a
Maryland corporation. 
 “Consultant” means a consultant or advisor only if such person (1) is a natural
person, (2) provides bona fide services to the Company, and (3) the services are not in connection with the offer or sale of securities in a capital-raising transaction, and do not directly or indirectly promote or maintain a market for
the Company’s securities. 
  

 2 

 “Director” means any individual who is a member of the Board of Directors;
provided, however, that any Director who is employed by the Company shall be considered an Employee under the Plan. 

“Disability” or “Disabled” means permanent and total disability as defined in Section 22(e)(3) of
the Code. 
 “Effective Date” means March 20, 2010, the date of approval by the Company’s stockholders
of the Plan. 
 “Employee” means any employee of the Company or of an Affiliate (including, without limitation,
an employee who is also serving as an officer or director of the Company or of an Affiliate), designated by the Committee to be eligible to be granted one or more Options under the Plan. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.

 “Fair Market Value” of a Share of Common Stock means: 

(1) If the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices are
regularly reported for the Common Stock, the closing or last price of the Common Stock on the Composite Tape or other comparable reporting system for the trading day immediately preceding the applicable date; 

(2) If the Common Stock is not traded on a national securities exchange but is traded on the over-the-counter market, if sales prices are
not regularly reported for the Common Stock for the trading day referred to in clause (1), and if bid and asked prices for the Common Stock are regularly reported, the mean between the bid and the asked price for the Common Stock at the close
of trading in the over-the-counter market for the trading day on which Common Stock was traded immediately preceding the applicable date; and 

(3) If the Common Stock is neither listed on a national securities exchange nor traded in the over-the-counter market, such value as the
Committee, in good faith, shall determine. 
 “Insider” means an individual who is, on the relevant date, an
executive officer, director or ten percent (10%) beneficial owner of any class of the Company’s equity securities that is registered pursuant to Section 12 of the Exchange Act, all as defined under Section 16 of the Exchange Act.

  

 3 

 “ISO” means an option meant to qualify as an incentive stock option under
Section 422 of the Code. 
 “Non-Qualified Option” means an option which is not intended to qualify as an
ISO. 
 “Option” means an ISO or Non-Qualified Option granted under the Plan. 

“Option Agreement” means an agreement between the Company and a Participant delivered pursuant to the Plan, in such form
as the Committee shall approve. 
 “Participant” means an Employee, Director or Consultant of the Company or an
Affiliate to whom one or more Options are granted under the Plan. As used herein, “Participant” shall include “Participant’s Survivors” or “Participant’s Permitted Transferees” where the context requires.

 “Permitted Transferee” means an Employee’s Family Member (as defined below) who has acquired
Non-Qualified Options from such Employee through a gift or a domestic relations order. For purposes of this Plan, “Family Member” means an Employee making a transfer of a Non-Qualified Option and his or her child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, brother-in-law, or sister-in-law, including adoptive relationships; any person sharing the Employee’s household (other than a tenant
or employee); a trust in which the foregoing persons have more than fifty percent (50%) of the beneficial interest; a foundation in which the foregoing persons control the management of assets; and any other entity in which the foregoing
persons own more than fifty percent (50%) of the voting interests. 
 “Plan” means this Neogenix Oncology,
Inc. 2005 Amended and Restated Stock Option Plan. 
 “Prior Plan” means the Neogenix Oncology, Inc. 2005
Employee, Director and Consultant Stock Option Plan in effect prior to the Effective Date. 
 “Section 409A”
means Code Section 409A and the regulations and other guidance issued thereunder. 
 “Shares” means shares
of the Common Stock as to which Options have been or may be granted under the Plan or any shares of capital stock into which the Shares are changed or for which they are exchanged within the provisions of Paragraph 3 of the Plan. The Shares
issued upon exercise of Options granted under the Plan may be authorized and unissued shares or shares held by the Company in its treasury, or both. 
  

 4 

 “Survivor” means a deceased Participant’s legal representatives and/or
any person or persons who acquired the Participant’s rights to an Option by will or by the laws of descent and distribution. 
  

	2.	PURPOSES OF THE PLAN. 

The Plan is intended to encourage ownership of Shares by Employees, Directors and Consultants in order to attract such people, to induce
them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to promote the success of the Company or of an Affiliate. The Plan provides for the granting of ISOs and Non-Qualified Options. 

 

	3.	SHARES SUBJECT TO THE PLAN. 

A. Number of Shares Available for Options: The number of Shares which may be issued under ISOs or Non-Qualified Options shall be
eleven million (11,000,000), or the equivalent of such number of Shares after the Committee, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance
with Paragraph 15 of the Plan. 
 B. Share Counting and Reacquired Shares: If an Option ceases to be
“outstanding”, in whole or in part, the Shares which were subject to such Option shall be available for the granting of other Options under the Plan. Any Option shall be treated as “outstanding” until such Option is exercised in
full, or terminates or expires under the provisions of the Plan, or by agreement of the parties to the pertinent Option Agreement. 

C. Prior Awards: Options granted before the Effective Date to persons who were not Employees, Directors or Consultants on the
grant date shall be governed by the terms of the Plan in effect prior to the Effective Date. From and after the Effective Date, Options shall be granted under the Plan solely to Employees, Directors and Consultants. 

 

	4.	ADMINISTRATION OF THE PLAN. 

Subject to the provisions of the Plan, the Committee is authorized to: 

 

	 	a.	Interpret the provisions of the Plan or of any Option or Option Agreement and to make all rules and determinations which it deems necessary or advisable for the
administration of the Plan; 

  

	 	b.	Determine which Employees, Directors and Consultants shall be granted Options; 

 

	 	c.	Determine the number of Shares for which an Option or Options shall be granted; 

 

	 	d.	Specify the terms and conditions upon which an Option or Options may be granted; and 

 

 5 

	 	e.	Adopt any sub-plans applicable to residents of any specified jurisdiction as it deems necessary or appropriate in order to comply with or take advantage of any tax laws
applicable to the Company or to Plan Participants or to otherwise facilitate the administration of the Plan, which sub-plans may include additional restrictions or conditions applicable to Options or Shares acquired upon exercise of Options.

 provided, however, that all such interpretations, rules, determinations, terms and conditions shall be made and prescribed in
the context of preserving the tax status under Section 422 of the Code of those Options which are designated as ISOs. Subject to the foregoing, the interpretation and construction by the Committee of any provisions of the Plan or of any Option
granted under it shall be final, unless otherwise determined by the Board of Directors. 
 If permissible under applicable law,
the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any portion of its responsibilities and powers to any other person selected by it. Any such allocation or
delegation may be revoked by the Committee at any time. 
  

	5.	ELIGIBILITY FOR PARTICIPATION. 

The Committee will, in its sole discretion, name the Participants in the Plan, provided, however, that each Participant must be an
Employee, Director or Consultant of the Company or of an Affiliate at the time an Option is granted. Notwithstanding the foregoing, the Committee may authorize the grant of an Option to a person not then an Employee, director or consultant of the
Company or of an Affiliate; provided, however, that the actual grant of such Option shall be conditioned upon such person becoming eligible to become a Participant at or prior to the time of the execution of the Option Agreement evidencing such
Option. ISOs may be granted only to Employees. Non-Qualified Options may be granted to any Employee, Director or Consultant of the Company or an Affiliate. The granting of any Option to any individual shall neither entitle that individual to, nor
disqualify him or her from, participation in any other grant of Options. 
  

	6.	TERMS AND CONDITIONS OF OPTIONS. 

Each Option shall be set forth in writing in an Option Agreement, duly executed by the Company and, to the extent required by law or
requested by the Company, by the Participant. The Committee may provide that Options be granted subject to such terms and conditions, consistent with the terms and conditions specifically required under this Plan, as the Committee may deem
appropriate including, without limitation, subsequent approval by the shareholders of the Company of this Plan or any amendments thereto. The Option Agreements shall be subject to at least the following terms and conditions: 

 

	 	A.	Non-Qualified Options: Each Option intended to be a Non-Qualified Option shall be subject to the terms and conditions which the Committee determines to be
appropriate and in the best interest of the Company, subject to the following minimum standards for any such Non-Qualified Option: 

  

	 	a.	Option Price: Each Option Agreement shall state the option price (per share) of the Shares covered by each Option, which option price shall be determined by the
Committee but shall not be less than 100% of the Fair Market Value per share of the Shares on the date of the grant of the Option; 

  

 6 

	 	b.	Each Option Agreement shall state the number of Shares to which it pertains; 

 

	 	c.	Each Option Agreement shall state the date or dates on which it first is exercisable and the date after which it may no longer be exercised, and may provide that the
Option rights accrue or become exercisable in installments over a period of months or years, or upon the occurrence of certain conditions or the attainment of stated goals or events; and 

 

	 	d.	Exercise of any Option may be conditioned upon the Participant’s execution of a Share purchase agreement in form satisfactory to the Committee providing for
certain protections for the Company and its other shareholders, including requirements that: 

  

	 	i.	The Participant’s or the Participant’s Survivors’ right to sell or transfer the Shares may be restricted; and 

 

	 	ii.	The Participant or the Participant’s Survivors may be required to execute letters of investment intent and must also acknowledge that the Shares will bear legends
noting any applicable restrictions. 

  

	 	B.	ISOs: Each Option intended to be an ISO shall be issued only to an Employee and be subject to the following terms and conditions, with such additional
restrictions or changes as the Committee determines are appropriate but not in conflict with Section 422 of the Code and relevant regulations and rulings of the Internal Revenue Service: 

 

	 	a.	Minimum standards: The ISO shall meet the minimum standards required of Non-Qualified Options, as described in Paragraph 6(A) above, except clause (a) thereunder.

  

	 	b.	Option Price: Immediately before the ISO is granted, if the Participant owns, directly or by reason of the applicable attribution rules in Section 424(d) of the
Code: 

  

	 	i.	10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, the Option price per share of the Shares covered by each
ISO shall not be less than 100% of the Fair Market Value per share of the Shares on the date of the grant of the Option; or 

  

 7 

	 	ii.	More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, the Option price per share of the Shares covered by each ISO
shall not be less than 110% of the said Fair Market Value on the date of grant. 

  

	 	c.	Term of Option: For Participants who own: 

  

	 	i.	10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than ten years from the
date of the grant or at such earlier time as the Option Agreement may provide; or 

  

	 	ii.	More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than five years from the date
of the grant or at such earlier time as the Option Agreement may provide. 

  

	 	d.	Limitation on Yearly Exercise: The Option Agreements shall restrict the amount of ISOs which may become exercisable in any calendar year (under this or any other ISO
plan of the Company or an Affiliate) so that the aggregate Fair Market Value (determined at the time each ISO is granted) of the stock with respect to which ISOs are exercisable for the first time by the Participant in any calendar year does not
exceed $100,000. 

  

	7.	EXERCISE OF OPTIONS AND ISSUE OF SHARES. 

An Option (or any part or installment thereof) shall be exercised by giving written notice to the Company or its designee, together with
provision for payment of the full purchase price in accordance with this Paragraph for the Shares as to which the Option is being exercised, and upon compliance with any other condition(s) set forth in the Option Agreement. Such notice shall be
signed by the person exercising the Option, shall state the number of Shares with respect to which the Option is being exercised and shall contain any representation required by the Plan or the Option Agreement. Payment of the purchase price for the
Shares as to which such Option is being exercised shall be made (a) in United States dollars in cash or by check, or (b) at the discretion of the Committee, through delivery of shares of Common Stock having a Fair Market Value equal as of
the date of the exercise to the cash exercise price of the Option and held for at least six months, or (c) at the discretion of the Committee, in accordance with a cashless exercise program established with a securities brokerage firm, and
approved by the Committee, or (d) at the discretion of the Committee, by any combination of (a), (b) and (c) above. Notwithstanding the foregoing, the Committee shall accept only such payment on exercise of an ISO as is permitted by
Section 422 of the Code. 
 The Company shall then reasonably promptly deliver the Shares as to which such Option was
exercised to the Participant (or to the Participant’s Survivors, as the case may be). In 
  

 8 

 
determining what constitutes “reasonably promptly,” it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law
or regulation (including, without limitation, state securities or “blue sky” laws) which requires the Company to take any action with respect to the Shares prior to their issuance. The Shares shall, upon delivery, be fully paid,
non-assessable Shares. 
 The Committee shall have the right to accelerate the date of exercise of any installment of any
Option; provided that the Committee shall not accelerate the exercise date of any installment of any Option granted to any Employee as an ISO (and not previously converted into a Non-Qualified Option pursuant to Paragraph 19) if such
acceleration would violate the annual vesting limitation contained in Section 422(d) of the Code, as described in Paragraph 6.B.d. 

The Committee may, in its discretion, amend any term or condition of an outstanding Option provided (i) such term or condition as
amended is permitted by the Plan, (ii) any such amendment shall be made only with the consent of the Participant to whom the Option was granted, or in the event of the death of the Participant, the Participant’s Survivors, if the amendment
is adverse to the Participant, and (iii) any such amendment of any ISO shall be made only after the Committee determines whether such amendment would constitute a “modification” of any Option which is an ISO (as that term is defined
in Section 424(h) of the Code) or would cause any adverse tax consequences for the holder of such ISO. 
  

	8.	RIGHTS AS A SHAREHOLDER. 

No Participant to whom an Option has been granted shall have rights as a shareholder with respect to any Shares covered by such Option,
except after due exercise of the Option and tender of the full purchase price for the Shares being purchased pursuant to such exercise and registration of the Shares in the Company’s share register in the name of the Participant. 

 

	9.	ASSIGNABILITY AND TRANSFERABILITY OF OPTIONS. 

By its terms, an Option granted to a Participant shall not be transferable by the Participant other than (i) by will or by the laws
of descent and distribution, or (ii) to a Permitted Transferee, if approved by the Committee in its discretion. Notwithstanding the foregoing, an ISO shall not be transferrable except in compliance with clause (i) above. The designation of
a beneficiary of an Option by a Participant, with the prior approval of the Committee and in such form as the Committee shall prescribe, shall not be deemed a transfer prohibited by this Paragraph. Except as provided above, an Option shall be
exercisable, during the Participant’s lifetime, only by such Participant (or by his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject
to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of any Option or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of any attachment or
similar process upon an Option, shall be null and void. 
  

 9 

	10.	EFFECT OF TERMINATION OF SERVICE OTHER THAN “FOR CAUSE” OR DEATH OR DISABILITY. 

Except as otherwise provided in a Participant’s Option Agreement, in the event of a termination of service (whether as an Employee,
Director or Consultant) with the Company or an Affiliate before the Participant has exercised an Option, the following rules apply: 
  

	 	a.	A Participant who ceases to be an Employee, Director or Consultant of the Company or of an Affiliate (for any reason other than termination “for cause”,
Disability, or death for which events there are special rules in Paragraphs 11, 12, and 13, respectively), may exercise any Option granted to him or her to the extent that the Option is exercisable on the date of such termination of service, but
only within such term as the Committee has designated in a Participant’s Option Agreement. 

  

	 	b.	Except as provided in Subparagraph (c) below, or Paragraph 12 or 13, in no event may an Option intended to be an ISO, be exercised later than three months after
the Participant’s termination of employment. 

  

	 	c.	The provisions of this Paragraph, and not the provisions of Paragraph 12 or 13, shall apply to a Participant who subsequently becomes Disabled or dies after the
termination of employment, director status or consultancy, provided, however, in the case of a Participant’s Disability or death within three months after the termination of employment, director status or consultancy, the Participant or the
Participant’s Survivors may exercise the Option within one year after the date of the Participant’s termination of service, but in no event after the date of expiration of the term of the Option. 

 

	 	d.	Notwithstanding anything herein to the contrary, if subsequent to a Participant’s termination of employment, termination of director status or termination of
consultancy, but prior to the exercise of an Option, the Board of Directors determines that, either prior or subsequent to the Participant’s termination, the Participant engaged in conduct which would constitute “cause”, then such
Participant shall forthwith cease to have any right to exercise any Option. 

  

	 	e.	A Participant to whom an Option has been granted under the Plan who is absent from work with the Company or with an Affiliate because of temporary disability (any
disability other than a permanent and total Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be deemed, by virtue of such absence alone, to have
terminated such Participant’s employment, director status or consultancy with the Company or with an Affiliate, except as the Committee may otherwise expressly provide. 

 

	 	f.	 Except as required by law or as set forth in a Participant’s Option Agreement, Options granted under the Plan shall not be affected by any change
of a 

  

 10 

	 	
Participant’s status within or among the Company and any Affiliates, so long as the Participant continues to be an Employee, Director or Consultant of the Company or any Affiliate. Except as
required by law or as set forth in a Participant’s Option Agreement, if a Participant is employed by an entity that ceases to be an Affiliate, the Participant will be treated as having terminated employment with the Company.

  

	11.	EFFECT OF TERMINATION OF SERVICE “FOR CAUSE”. 

Except as otherwise provided in a Participant’s Option Agreement, the following rules apply if the Participant’s service
(whether as an Employee, Director or Consultant) with the Company or an Affiliate is terminated “for cause” prior to the time that all his or her outstanding Options have been exercised: 

 

	 	a.	All outstanding and unexercised Options as of the time the Participant is notified his or her service is terminated “for cause” will immediately be forfeited.

  

	 	b.	For purposes of this Plan, “cause” shall include (and is not limited to) dishonesty with respect to the Company or any Affiliate, insubordination, substantial
malfeasance or non-feasance of duty, unauthorized disclosure of confidential information, breach by the Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or similar agreement between the Participant
and the Company or any Affiliate, and conduct substantially prejudicial to the business of the Company or any Affiliate. The determination of the Committee as to the existence of “cause” will be conclusive on the Participant and the
Company. 

  

	 	c.	“Cause” is not limited to events which have occurred prior to a Participant’s termination of service, nor is it necessary that the Committee’s
finding of “cause” occur prior to termination. If the Committee determines, subsequent to a Participant’s termination of service but prior to the exercise of an Option, that either prior or subsequent to the Participant’s
termination the Participant engaged in conduct which would constitute “cause,” then the right to exercise any Option is forfeited. 

  

	 	d.	Any definition in an agreement between the Participant and the Company or an Affiliate, which contains a conflicting definition of “cause” for termination and
which is in effect at the time of such termination, shall supersede the definition in this Plan with respect to that Participant. 

  

	12.	EFFECT OF TERMINATION OF SERVICE FOR DISABILITY. 

Except as otherwise provided in a Participant’s Option Agreement, a Participant who ceases to be an Employee, Director or Consultant
of the Company or of an Affiliate by reason of Disability may exercise any Option granted to such Participant: 
  

	 	a.	To the extent that the Option has become exercisable but has not been exercised on the date of Disability; and 

 

 11 

	 	b.	In the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of Disability of any additional vesting rights that
would have accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued in the current vesting period prior to the date of Disability. 

A Disabled Participant may exercise such rights only within the period ending one year after the date of the Participant’s
termination of employment, directorship or consultancy, as the case may be, notwithstanding that the Participant might have been able to exercise the Option as to some or all of the Shares on a later date if the Participant had not become Disabled
and had continued to be an Employee, Director or Consultant or, if earlier, within the originally prescribed term of the Option. 

The Committee shall make the determination both of whether Disability has occurred and the date of its occurrence (unless a procedure for
such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination). If requested, the Participant shall be examined by a physician selected or approved by
the Committee, the cost of which examination shall be paid for by the Company. 
  

	13.	EFFECT OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT. 

Except as otherwise provided in a Participant’s Option Agreement, in the event of the death of a Participant while the Participant is
an Employee, Director or Consultant of the Company or of an Affiliate, such Option may be exercised by the Participant’s Survivors: 
  

	 	a.	To the extent that the Option has become exercisable but has not been exercised on the date of death; and 

 

	 	b.	In the event rights to exercise the Option accrue periodically, to the extent of a pro rata portion through the date of death of any additional vesting rights that
would have accrued on the next vesting date had the Participant not died. The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant’s date of death. 

If the Participant’s Survivors wish to exercise the Option, they must take all necessary steps to exercise the Option within one
year after the date of death of such Participant, notwithstanding that the decedent might have been able to exercise the Option as to some or all of the Shares on a later date if he or she had not died and had continued to be an Employee, Director
or Consultant or, if earlier, within the originally prescribed term of the Option. 
  

 12 

	14.	DISSOLUTION OR LIQUIDATION OF THE COMPANY. 

Upon the dissolution or liquidation of the Company, all Options granted under this Plan which as of such date shall not have been
exercised will terminate and become null and void; provided, however, that if the rights of a Participant or a Participant’s Survivors have not otherwise terminated and expired, the Participant or the Participant’s Survivors will have the
right immediately prior to such dissolution or liquidation to exercise any Option to the extent that the Option is exercisable as of the date immediately prior to such dissolution or liquidation. 

 

	15.	ADJUSTMENTS. 

 Upon the
occurrence of any of the following events, a Participant’s rights with respect to any Option granted to him or her hereunder which has not previously been exercised in full shall be adjusted as hereinafter provided, unless otherwise
specifically provided in the Participant’s Option Agreement: 
 A. Stock Dividends and Stock Splits. If (i) the
shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii) additional shares or new or
different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Common Stock, the number of shares of Common Stock deliverable upon the exercise of such Option may be appropriately
increased or decreased proportionately, and appropriate adjustments may be made including, in the purchase price per share, to reflect such events. 

B. Corporate Transactions. If the Company is to be consolidated with or acquired by another entity in a merger, sale of all or
substantially all of the Company’s assets other than a transaction to merely change the state of incorporation (a “Corporate Transaction”), or in the event of a Change in Control, the Committee or the board of directors of any entity
assuming the obligations of the Company hereunder (the “Successor Board”), shall, as to outstanding Options, either (i) make appropriate provision for the continuation of such Options by substituting on an equitable basis for the
Shares then subject to such Options either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii) upon written
notice to the Participants, provide that all Options must be exercised (either to the extent then exercisable or, at the discretion of the Committee or, upon a Change in Control, all Options being made fully exercisable for purposes of this
Subparagraph), within a specified number of days of the date of such notice (or, if shorter, during their remaining term), at the end of which period the Options shall terminate; or (iii) terminate all Options in exchange for a cash payment
equal to the excess of the Fair Market Value of the Shares subject to such Options (either to the extent then exercisable or, at the discretion of the Committee, all Options being made fully exercisable for purposes of this Subparagraph) over the
exercise price thereof. 
 C. Recapitalization or Reorganization. In the event of a recapitalization or reorganization of
the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of 

 

 13 

 
Common Stock, a Participant upon exercising an Option after the recapitalization or reorganization shall be entitled to receive for the purchase price paid upon such exercise the number of
replacement securities which would have been received if such Option had been exercised prior to such recapitalization or reorganization. 

D. Modification of ISOs. Notwithstanding the foregoing, any adjustments made pursuant to Subparagraph A, B or C above with respect
to ISOs shall be made only after the Committee determines whether such adjustments would constitute a “modification” of such ISOs (as that term is defined in Section 424(h) of the Code) or would cause any adverse tax consequences for
the holders of such ISOs. If the Committee determines that such adjustments made with respect to ISOs would constitute a modification of such ISOs, it may refrain from making such adjustments, unless the holder of an ISO specifically requests in
writing that such adjustment be made and such writing indicates that the holder has full knowledge of the consequences of such “modification” on his or her income tax treatment with respect to the ISO. 

 

	16.	ISSUANCES OF SECURITIES. 

Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of
stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Options. Except as expressly provided herein, no adjustments shall be made for dividends paid in cash or in
property (including without limitation, securities) of the Company. 
  

	17.	FRACTIONAL SHARES. 

 No
fractional shares shall be issued under the Plan and the person exercising such right shall receive from the Company cash in lieu of such fractional shares equal to the Fair Market Value thereof. 

 

	18.	CONVERSION OF ISOs INTO NON-QUALIFIED OPTIONS; TERMINATION OF ISOs. 

The Committee, at the written request of any Participant, may in its discretion take such actions as may be necessary to convert such
Participant’s ISOs (or any portions thereof) that have not been exercised on the date of conversion into Non-Qualified Options at any time prior to the expiration of such ISOs, regardless of whether the Participant is an employee of the Company
or an Affiliate at the time of such conversion. At the time of such conversion, the Committee (with the consent of the Participant) may impose such conditions on the exercise of the resulting Non-Qualified Options as the Committee in its discretion
may determine, provided that such conditions shall not be inconsistent with this Plan. Nothing in the Plan shall be deemed to give any Participant the right to have such Participant’s ISOs converted into Non-Qualified Options, and no such
conversion shall occur until and unless the Committee takes appropriate action. The Committee, with the consent of the Participant, may also terminate any portion of any ISO that has not been exercised at the time of such conversion. 

 

 14 

	19.	WITHHOLDING. 

 In the
event that any federal, state, or local income taxes, employment taxes, Federal Insurance Contributions Act (“F.I.C.A.”) withholdings or other amounts are required by applicable law or governmental regulation to be withheld from the
Participant’s salary, wages or other remuneration in connection with the exercise of an Option or a Disqualifying Disposition (as defined in Paragraph 20), the Company may withhold from the Participant’s compensation, if any, or may
require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs or employed the Participant, the statutory minimum amount of such withholdings unless a different withholding arrangement, including the
use of shares of the Company’s Common Stock, is authorized by the Committee (and permitted by law). For purposes hereof, the Fair Market Value of the shares withheld for purposes of payroll withholding shall be determined in the manner provided
in Paragraph 1 above, as of the most recent practicable date prior to the date of exercise. If the Fair Market Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the
difference in cash to the Company or the Affiliate employer. 
  

	20.	NOTICE TO COMPANY OF DISQUALIFYING DISPOSITION. 

Each Employee who receives an ISO must agree to notify the Company in writing immediately after the Employee makes a Disqualifying
Disposition of any shares acquired pursuant to the exercise of an ISO. A Disqualifying Disposition is defined in Section 424(c) of the Code and includes any disposition (including any sale or gift) of such shares before the later of
(a) two years after the date the Employee was granted the ISO, or (b) one year after the date the Employee acquired Shares by exercising the ISO, except as otherwise provided in Section 424(c) of the Code. If the Employee has died
before such stock is sold, these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter. 
  

	21.	TERMINATION OF THE PLAN. 

The Plan will terminate on 10 years after adoption, the date which is ten years from the earlier of the date of its adoption by the
Board of Directors and the date of its approval by the shareholders. The Plan may be terminated at an earlier date by vote of the shareholders or the Board of Directors of the Company; provided, however, that any such earlier termination shall not
affect any Option Agreements executed prior to the effective date of such termination. 
  

	22.	AMENDMENT, MODIFICATION, TERMINATION AND TAX COMPLIANCE. 

A. Amendment, Modification, and Termination: Subject to the terms of the Plan, the Committee or the Board of Directors may at any
time and from time to time, alter, amend, suspend, or terminate the Plan in whole or in part or alter or amend any outstanding Options or Option Agreements. 

B. Options Previously Granted: Notwithstanding any other provision of the Plan to the contrary, no termination, amendment, or
modification of the Plan or any amendment of any outstanding Options or Option Agreements shall adversely affect in any material way any Option 

 

 15 

 
previously granted under the Plan, without the written consent of the Participant holding such Option; provided that no consent is required for any amendment the Committee deems necessary or
appropriate to comply with applicable legal or tax requirements, including to the extent necessary to qualify the shares issuable upon exercise of any outstanding Options granted, or Options to be granted, under the Plan for listing on any national
securities exchange. 
 C. Shareholder Approval Required for Certain Amendments: Shareholder approval will be required
for any amendment of the Plan that does any of the following: (a) permits the grant of any Option with an exercise price less than the Fair Market Value of the Shares on the date of grant; or (b) reduces the exercise price of an
outstanding Option, either by lowering the exercise price or by canceling an outstanding Option and granting a replacement Option with a lower exercise price. 

D. Compliance with Section 409A: It is intended that Options granted under this Plan are exempt from Section 409A. The
Plan shall be administered and interpreted in accordance with that intent. By way of example, the following rules shall apply: 
  

	 	a.	Any adjustment or modification to an Option shall be made in compliance with Section 409A (e.g., any adjustment to an Option under Paragraph 15 shall be
made in accordance with the requirements of Section 409A); 

  

	 	b.	The determination of the Fair Market Value of a Share for purposes of establishing the exercise price of an Option shall be made in accordance with the requirements of
Section 409A; and 

  

	 	c.	Any right to amend, terminate or modify the Plan or any outstanding Option or Option Agreement is subject to the requirements and limitations of Section 409A.

 While the Company intends for Options to be exempt from Section 409A, neither the Company nor the Committee shall be
liable to any person for the tax consequences of any failure to comply with the requirements of Section 409A or any other tax consequences relating to Options under this Plan. 

 

	23.	EMPLOYMENT OR OTHER RELATIONSHIP. 

Nothing in this Plan or any Option Agreement shall be deemed to prevent the Company or an Affiliate from terminating the employment,
consultancy or director status of a Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any Participant a right to be retained in employment or other service by the Company
or any Affiliate for any period of time. 
  

	24.	SUCCESSORS. 

 All
obligations of the Company under the Plan with respect to Options granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or
otherwise, of all or substantially all of the business, stock and/or assets of the Company. 
  

 16 

	25.	GENERAL PROVISIONS. 

 A.
Gender and Number: Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine; the plural shall include the singular and the singular shall include the plural. 

B. Severability: If any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall
not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included. 

C. Requirements of Law: The granting of Options and the issuance of Shares under the Plan shall be subject to all applicable laws,
rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required. 

D. Securities Law Compliance: With respect to Insiders, transactions under this Plan are intended to comply with all applicable
conditions of Rule 16b-3 or its successors under the Exchange Act, unless determined otherwise by the Board of Directors. To the extent any provision of the Plan or action by the Committee fails to so comply, it shall be deemed null and void, to the
extent permitted by law and deemed advisable by the Board of Directors. 
 E. Listing: The Company may use reasonable
endeavors to register Shares allotted pursuant to the exercise of an Option with the United States Securities and Exchange Commission or to effect compliance with the registration, qualification, and listing requirements of any national securities
laws or stock exchange. 
 F. Inability to Obtain Authority: The inability of the Company to obtain authority from any
regulatory body having jurisdiction, which authority is deemed by the Company’s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or
sell such Shares as to which such requisite authority shall not have been obtained. 
 G. No Additional Rights: Neither
the grant of Options nor any benefits arising under this Plan shall constitute part of an employment contract between the Participant and the Company or any Affiliate, and accordingly, this Plan and the benefits hereunder may be terminated at any
time in the sole and exclusive discretion of the Board of Directors without giving rise to liability on the part of the Company or any Affiliate for severance payments. 

H. Uncertificated Shares: To the extent that the Plan provides for issuance of certificates to reflect the transfer of Shares, the
transfer of such Shares may be effected on a noncertificated basis, to the extent not prohibited by applicable law or the rules of any stock exchange. 

I. Governing Law: The Plan and each Option Agreement shall be governed by the laws of the State of Maryland, excluding any
conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of the Plan to the substantive law of another 

 

 17 

 
jurisdiction. Unless otherwise provided in the Option Agreement, recipients of an Option under the Plan are deemed to submit to the exclusive jurisdiction and venue of the federal or state courts
located in the State of Maryland, County of Prince Georges, to resolve any and all issues that may arise out of or relate to the Plan or any related Option Agreement. 

 

 18Form of Non-Qualified Stock Option Agreement

 Exhibit 10.9 

NON-QUALIFIED STOCK OPTION AGREEMENT 

NEOGENIX ONCOLOGY, INC. 

AGREEMENT made as of the              day of
             20    , between NEOGENIX ONCOLOGY INC. (the “Company”), a Maryland corporation having a principal place of business in Rockville, Maryland and
[            ] (the “Participant”). 
 WHEREAS, the
Company desires to grant to the Participant an Option to purchase shares of its common stock, $0.00001 par value per share (the “Shares”), under and for the purposes set forth in the Company’s 2005 Amended and Restated Stock Option
Plan (the “Plan”); 
 WHEREAS, the Company and the Participant understand and agree that any terms used and not
defined herein have the same meanings as in the Plan; and 
 WHEREAS, the Company and the Participant each intend that the
Option granted herein shall be a Non-Qualified Option. 
 NOW, THEREFORE, in consideration of the mutual covenants hereinafter
set forth and for other good and valuable consideration, the parties hereto agree as follows: 
 1. GRANT OF OPTION.

 The Company hereby grants to the Participant the right and option to purchase all or any part of an aggregate of
[            ] Shares, on the terms and conditions and subject to all the limitations set forth herein, under United States securities and tax laws, and in the Plan, which is incorporated
herein by reference. The Participant acknowledges receipt of a copy of the Plan. 
 2. PURCHASE PRICE. 

The purchase price of the Shares covered by the Option shall be
$[            ] per Share, subject to adjustment, as provided in the Plan, in the event of a stock split, reverse stock split or other events affecting the holders of Shares (the
“Purchase Price”). Payment shall be made in accordance with Paragraph 7 of the Plan. 
 3. EXERCISABILITY OF
OPTION. 
 Subject to the terms and conditions set forth in this Agreement, the Option granted hereby shall become
exercisable as follows: 
  

					
	 On the first anniversary of the date of this Agreement
	 	up to [            ] Shares	 	
			
	 On the second anniversary of the date of this Agreement
	 	an additional [            ] Shares	 	

					
	 On the third anniversary of the date of this Agreement
	 	an additional [            ] Shares	 	
			
	 On the fourth anniversary of the date of this Agreement
	 	an additional [            ] Shares	 	)

 The foregoing rights are
cumulative and are subject to the other terms and conditions of this Agreement and the Plan. 
 4. TERM OF OPTION.

 The Option shall terminate five (5) years from the date of this Agreement. 

5. METHOD OF EXERCISING OPTION. 

Subject to the terms and conditions of this Agreement, the Option may be exercised by written notice to the Company or its designee, in
substantially the form of Exhibit A attached hereto. Such notice shall state the number of Shares with respect to which the Option is being exercised and shall be signed by the person exercising the Option. Payment of the purchase price
for such Shares shall be made in accordance with Paragraph 7 of the Plan. The Company shall deliver a certificate or certificates representing such Shares as soon as practicable after the notice shall be received, provided, however, that the Company
may delay issuance of such Shares until completion of any action or obtaining of any consent, which the Company deems necessary under any applicable law (including, without limitation, state securities or “blue sky” laws). The certificate
or certificates for the Shares as to which the Option shall have been so exercised shall be registered in the Company’s share register in the name of the person so exercising the Option (or, if the Option shall be exercised by the Participant
and if the Participant shall so request in the notice exercising the Option, shall be registered in the name of the Participant and another person jointly, with right of survivorship) and shall be delivered as provided above to or upon the written
order of the person exercising the Option. In the event the Option shall be exercised by any person other than the Participant, such notice shall be accompanied by appropriate proof of the right of such person to exercise the Option. All Shares that
shall be purchased upon the exercise of the Option as provided herein shall be fully paid and nonassessable. 
 6. PARTIAL
EXERCISE. 
 Exercise of this Option to the extent above stated may be made in part at any time and from time to time within
the above limits, except that no fractional share shall be issued pursuant to this Option. 
 7. NON-ASSIGNABILITY.

 The Option shall not be transferable by the Participant otherwise than by will or by the laws of descent and distribution or
pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act or the rules thereunder. 

 

 2 

 
However, the Participant, with the approval of the Administrator, may transfer the Option for no consideration to or for the benefit of the Participant’s Immediate Family (including, without
limitation, to a trust for the benefit of the Participant’s Immediate Family or to a partnership or limited liability company for one or more members of the Participant’s Immediate Family), subject to such limits as the Administrator may
establish, and the transferee shall remain subject to all the terms and conditions applicable to the Option prior to such transfer and each such transferee shall so acknowledge in writing as a condition precedent to the effectiveness of such
transfer. The term “Immediate Family” shall mean the Participant’s spouse, former spouse, parents, children, stepchildren, adoptive relationships, sisters, brothers, nieces, nephews and grandchildren (and, for this purpose, shall also
include the Participant.) Except as provided in the previous sentence, the Option shall be exercisable, during the Participant’s lifetime, only by the Participant (or, in the event of legal incapacity or incompetency, by the Participant’s
guardian or representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge,
hypothecation or other disposition of the Option or of any rights granted hereunder contrary to the provisions of this Section 7, or the levy of any attachment or similar process upon the Option shall be null and void. 

8. NO RIGHTS AS STOCKHOLDER UNTIL EXERCISE. 

The Participant shall have no rights as a stockholder with respect to Shares subject to this Agreement until registration of the Shares
in the Company’s share register in the name of the Participant. Except as is expressly provided in the Plan with respect to certain changes in the capitalization of the Company, no adjustment shall be made for dividends or similar rights for
which the record date is prior to the date of such registration. 
 9. ADJUSTMENTS. 

The Plan contains provisions covering the treatment of Options in a number of contingencies such as stock splits and mergers. Provisions
in the Plan for adjustment with respect to stock subject to Options and the related provisions with respect to successors to the business of the Company are hereby made applicable hereunder and are incorporated herein by reference. 

10. TAXES. 

The Participant acknowledges that upon exercise of the Option the Participant will be deemed to have taxable income measured by the
difference between the then fair market value of the Shares received upon exercise and the price paid for such Shares pursuant to this Agreement. The Participant acknowledges that any income or other taxes due from him or her with respect to this
Option or the Shares issuable pursuant to this Option shall be the Participant’s responsibility. 
 The Participant agrees
that the Company may withhold from the Participant’s remuneration, if any, the minimum statutory amount of federal, state and local withholding taxes attributable to such amount that is considered compensation includable in such person’s
gross income. At the Company’s discretion, the amount required to be withheld may be withheld in 
  

 3 

 
cash from such remuneration, or in kind from the Shares otherwise deliverable to the Participant on exercise of the Option. The Participant further agrees that, if the Company does not withhold
an amount from the Participant’s remuneration sufficient to satisfy the Company’s income tax withholding obligation, the Participant will reimburse the Company on demand, in cash, for the amount under-withheld. 

11. PURCHASE FOR INVESTMENT. 

Unless the offering and sale of the Shares to be issued upon the particular exercise of the Option shall have been effectively registered
under the Securities Act of 1933, as now in force or hereafter amended (the “1933 Act”), the Company shall be under no obligation to issue the Shares covered by such exercise unless and until the following conditions have been fulfilled:

  

	 	(a)	The person(s) who exercise the Option shall warrant to the Company, at the time of such exercise, that such person(s) are acquiring such Shares for their own respective
accounts, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person(s) acquiring such Shares shall be bound by the provisions of the following legend which shall be
endorsed upon the certificate(s) evidencing the Shares issued pursuant to such exercise: 

 “The shares
represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1) either (a) a Registration Statement with respect to such shares shall be
effective under the Securities Act of 1933, as amended, or (b) the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2) there shall have been
compliance with all applicable state securities laws;” and 
  

	 	(b)	If the Company so requires, the Company shall have received an opinion of its counsel that the Shares may be issued upon such particular exercise in compliance with the
1933 Act without registration thereunder. Without limiting the generality of the foregoing, the Company may delay issuance of the Shares until completion of any action or obtaining of any consent, which the Company deems necessary under any
applicable law (including without limitation state securities or “blue sky” laws). 

 12.
RESTRICTIONS ON TRANSFER OF SHARES. 
 12.1 The Shares acquired by the Participant pursuant to the exercise of the Option
granted hereby shall not be transferred by the Participant except as permitted herein. 
  

 4 

 12.2 It shall be a condition precedent to the validity of any sale or other transfer of any
Shares by the Participant that the following restrictions be complied with (except as hereinafter otherwise provided): 
  

	 	(i)	No Shares owned by the Participant may be sold, pledged or otherwise transferred (including by gift or devise) to any person or entity, voluntarily, or by operation of
law, except in accordance with the terms and conditions hereinafter set forth. 

  

	 	(ii)	Before selling or otherwise transferring all or part of the Shares, the Participant shall give written notice of such intention to the Company, which notice shall
include the name of the proposed transferee, the proposed purchase price per share, the terms of payment of such purchase price and all other matters relating to such sale or transfer and shall be accompanied by a copy of the binding written
agreement of the proposed transferee to purchase the Shares of the Participant. Such notice shall constitute a binding offer by the Participant to sell to the Company such number of the Shares then held by the Participant as are proposed to be sold
in the notice at the monetary price per share designated in such notice, payable on the terms offered to the Participant by the proposed transferee (provided, however, that the Company shall not be required to meet any non-monetary terms of the
proposed transfer, including, without limitation, delivery of other securities in exchange for the Shares proposed to be sold). The Company shall give written notice to the Participant as to whether such offer has been accepted in whole by the
Company within sixty days after its receipt of written notice from the Participant. The Company may only accept such offer in whole and may not accept such offer in part. Such acceptance notice shall fix a time, location and date for the closing on
such purchase (“Closing Date”) which shall not be less than ten nor more than sixty days after the giving of the acceptance notice, provided, however, if any of the Shares to be sold pursuant to this Section 12.2 have been held by the
Participant for less than six months, then the Closing Date may be extended by the Company until no more than ten days after such Shares have been held by the Participant for six months. The place for such closing shall be at the Company’s
principal office. At such closing, the Participant shall accept payment as set forth herein and shall deliver to the Company in exchange therefor certificates for the number of Shares stated in the notice accompanied by duly executed instruments of
transfer. 

  

	 	(iii)	If the Company shall fail to accept any such offer, the Participant shall be free to sell all, but not less than all, of the Shares set forth in his or her notice to
the designated transferee at the price and terms designated in the Participant’s notice, provided that (i) such sale is consummated within six months after the giving of notice by the Participant to the Company as aforesaid, and
(ii) the transferee first agrees in writing to be bound by the provisions of this Section 12 so that such transferee (and all subsequent transferees) shall thereafter only be permitted to sell or transfer the Shares in accordance with the
terms hereof. After the expiration of such six months, the provisions of this Section 12.2 shall again apply with respect to any proposed voluntary transfer of the Participant’s Shares. 

 

	 	(iv)	 The restrictions on transfer contained in this Section 12.2 shall not apply to transfers expressly permitted under Section 7 hereof; provided
however, that in 

  

 5 

	 	
any such event the Shares so transferred in the hands of each such Permitted Transferee shall remain subject to this Agreement, and each such Permitted Transferee shall so acknowledge in writing
as a condition precedent to the effectiveness of such transfer. 

  

	 	(v)	The provisions of this Section 12.2 may be waived by the Company. Any such waiver may be unconditional or based upon such conditions as the Company may impose.

 12.3 In the event that the Participant or his or her successor in interest fails to deliver the Shares to be
repurchased by the Company under this Agreement, the Company may elect (a) to establish a segregated account in the amount of the repurchase price, such account to be turned over to the Participant or his or her successor in interest upon
delivery of such Shares, and (b) immediately to take such action as is appropriate to transfer record title of such Shares from the Participant to the Company and to treat the Participant and such Shares in all respects as if delivery of such
Shares had been made as required by this Agreement. The Participant hereby irrevocably grants the Company a power of attorney which shall be coupled with an interest for the purpose of effectuating the preceding sentence. 

12.4 If the Company shall pay a stock dividend or declare a stock split on or with respect to any of its common stock, or otherwise
distribute securities of the Company to the holders of its common stock, the number of shares of stock or other securities of Company issued with respect to the shares then subject to the restrictions contained in this Agreement shall be added to
the Shares subject to the Company’s rights to repurchase pursuant to this Agreement. If the Company shall distribute to its stockholders shares of stock of another corporation, the shares of stock of such other corporation, distributed with
respect to the Shares then subject to the restrictions contained in this Agreement, shall be added to the Shares subject to the Company’s rights to repurchase pursuant to this Agreement. 

12.5 If the outstanding shares of common stock of the Company shall be subdivided into a greater number of shares or combined into a
smaller number of shares, or in the event of a reclassification of the outstanding shares of common stock of the Company, or if the Company shall be a party to a merger, consolidation or capital reorganization, there shall be substituted for the
Shares then subject to the restrictions contained in this Agreement such amount and kind of securities as are issued in such subdivision, combination, reclassification, merger, consolidation or capital reorganization in respect of the Shares subject
immediately prior thereto to the Company’s rights to repurchase pursuant to this Agreement. 
 12.6 The Company shall not
be required to transfer any Shares on its books which shall have been sold, assigned or otherwise transferred in violation of this Agreement, or to treat as owner of such Shares, or to accord the right to vote as such owner or to pay dividends to,
any person or organization to which any such Shares shall have been so sold, assigned or otherwise transferred, in violation of this Agreement. 

12.7 The provisions of Sections 12.1 and 12.2 shall terminate upon the consummation of a public offering of any of the Company’s
securities pursuant to a registration statement filed with the Securities and Exchange Commission pursuant to the 1933 Act, in which offering the aggregate gross proceeds to the Company exceed $40,000,000. 

 

 6 

 12.8 If, in connection with a registration statement filed by the Company pursuant to the
1933 Act, the Company or its underwriter so requests, the Participant will agree not to sell any Shares for a period not to exceed 180 days following the effectiveness of such registration. 

12.9 The Participant acknowledges and agrees that neither the Company, its shareholders nor its directors and officers, has any duty or
obligation to disclose to the Participant any material information regarding the business of the Company or affecting the value of the Shares before, at the time of, or following a termination of the employment of the Participant by the Company,
including, without limitation, any information concerning plans for the Company to make a public offering of its securities or to be acquired by or merged with or into another firm or entity. 

12.10 All certificates representing the Shares to be issued to the Participant pursuant to this Agreement shall have endorsed thereon a
legend substantially as follows: “The shares represented by this certificate are subject to restrictions set forth in a Non-Qualified Stock Option Agreement dated             ,
20     with this Company, a copy of which Agreement is available for inspection at the offices of the Company or will be made available upon request.” 

13. NO OBLIGATION TO MAINTAIN RELATIONSHIP. 

The Company is not by the Plan or this Option obligated to continue the Participant as an employee, director or consultant of the Company
or an Affiliate. The Participant acknowledges: (i) that the Plan is discretionary in nature and may be suspended or terminated by the Company at any time; (ii) that the grant of the Option is a one-time benefit which does not create any
contractual or other right to receive future grants of options, or benefits in lieu of options; (iii) that all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the
number of shares subject to each option, the option price, and the time or times when each option shall be exercisable, will be at the sole discretion of the Company; (iv) that the Participant’s participation in the Plan is voluntary;
(v) that the value of the Option is an extraordinary item of compensation which is outside the scope of the Participant’s employment contract, if any; and (vi) that the Option is not part of normal or expected compensation for
purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments. 

14. NOTICES. 

Any notices required or permitted by the terms of this Agreement or the Plan shall be given by recognized courier service, facsimile,
registered or certified mail, return receipt requested, addressed as follows: 
  

					
	If to the Company:	  		  	
		  	Neogenix Oncology, Inc.	  	
		  	 445 Northern Boulevard, Suite 24

Great Neck, NY 11021
	  	
		  	 Attn: Chief Financial Officer
	  	

  

 7 

					
	If to the Participant:	  	  
	  	
		  	  
	  	
		  	  
	  	

 or to such other address or addresses of which notice in the same manner has previously been given. Any such notice
shall be deemed to have been given upon the earlier of receipt, one business day following delivery to a recognized courier service or three business days following mailing by registered or certified mail. 

15. GOVERNING LAW. 

This Agreement shall be construed and enforced in accordance with the law of the State of Maryland, without giving effect to the
conflict of law principles thereof. For the purpose of litigating any dispute that arises under this Agreement, the parties hereby consent to exclusive jurisdiction in Maryland and agree that such litigation shall be conducted in the courts of
Montgomery, Maryland or the federal courts of the United States for the District of Maryland, Greenbelt Division. 
 16.
BENEFIT OF AGREEMENT. 
 Subject to the provisions of the Plan and the other provisions hereof, this Agreement shall be
for the benefit of and shall be binding upon the heirs, executors, administrators, successors and assigns of the parties hereto. 

17. ENTIRE AGREEMENT. 

This Agreement, together with the Plan, embodies the entire agreement and understanding between the parties hereto with respect to the
subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement not expressly set forth in this Agreement shall affect
or be used to interpret, change or restrict, the express terms and provisions of this Agreement, provided, however, in any event, this Agreement shall be subject to and governed by the Plan. 

18. MODIFICATIONS AND AMENDMENTS. 

The terms and provisions of this Agreement may be modified or amended as provided in the Plan. 

 

 8 

 19. WAIVERS AND CONSENTS. 

Except as provided in the Plan, the terms and provisions of this Agreement may be waived, or consent for the departure therefrom granted,
only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or consent with respect to any other terms or provisions of this
Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and shall not constitute a continuing waiver or consent. 

20. DATA PRIVACY. 

By entering into this Agreement, the Participant: (i) authorizes the Company and each Affiliate, and any agent of the Company or any
Affiliate administering the Plan or providing Plan record keeping services, to disclose to the Company or any of its Affiliates such information and data as the Company or any such Affiliate shall request in order to facilitate the grant of options
and the administration of the Plan; (ii) waives any data privacy rights he or she may have with respect to such information; and (iii) authorizes the Company and each Affiliate to store and transmit such information in electronic form.

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 
  

 9 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer, and the Participant has hereunto set his or her hand, all as of the day and year first above written. 
  

			
	 NEOGENIX ONCOLOGY, INC.

		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

	
	  

	
[                    ]

	 Participant

 

 10 

 Exhibit A 

NOTICE OF EXERCISE OF NON-QUALIFIED STOCK OPTION 

[Form For Unregistered Shares] 

To: Neogenix Oncology, Inc. 
 Ladies and
Gentlemen: 
 I hereby exercise my Non-Qualified Stock Option to purchase
             shares (the “Shares”) of the common stock, $0.00001 par value, of Neogenix Oncology, Inc. (the “Company”), at the exercise price of
$             per share, pursuant to and subject to the terms of that certain Non-Qualified Stock Option Agreement between the undersigned and the Company dated
            , 20        . 

I am aware that the Shares have not been registered under the Securities Act of 1933, as amended (the “1933 Act”), or any state
securities laws. I understand that the reliance by the Company on exemptions under the 1933 Act is predicated in part upon the truth and accuracy of the statements by me in this Notice of Exercise. 

I hereby represent and warrant that (1) I have been furnished with all information which I deem necessary to evaluate the merits and
risks of the purchase of the Shares; (2) I have had the opportunity to ask questions concerning the Shares and the Company and all questions posed have been answered to my satisfaction; (3) I have been given the opportunity to obtain any
additional information I deem necessary to verify the accuracy of any information obtained concerning the Shares and the Company; and (4) I have such knowledge and experience in financial and business matters that I am able to evaluate the
merits and risks of purchasing the Shares and to make an informed investment decision relating thereto. 
 I hereby represent
and warrant that I am purchasing the Shares for my own personal account for investment and not with a view to the sale or distribution of all or any part of the Shares. 

I understand that because the Shares have not been registered under the 1933 Act, I must continue to bear the economic risk of the
investment for an indefinite time and the Shares cannot be sold unless the Shares are subsequently registered under applicable federal and state securities laws or an exemption from such registration requirements is available. 

I agree that I will in no event sell or distribute or otherwise dispose of all or any part of the Shares unless (1) there is an
effective registration statement under the 1933 Act and applicable state securities laws covering any such transaction involving the Shares or (2) the Company receives an opinion of my legal counsel (concurred in by legal counsel for the
Company) stating that such transaction is exempt from registration or the Company otherwise satisfies itself that such transaction is exempt from registration. 
  

 A-1 

 I consent to the placing of a legend on my certificate for the Shares stating that the
Shares have not been registered and setting forth the restriction on transfer contemplated hereby and to the placing of a stop transfer order on the books of the Company and with any transfer agents against the Shares until the Shares may be legally
resold or distributed without restriction. 
 I understand that at the present time Rule 144 of the Securities and Exchange
Commission (the “SEC”) may not be relied on for the resale or distribution of the Shares by me. I understand that the Company has no obligation to me to register the sale of the Shares with the SEC and has not represented to me that it
will register the sale of the Shares. 
 I understand the terms and restrictions on the right to dispose of the Shares set forth
in the Non-Qualified Stock Option Agreement, which I have carefully reviewed. I consent to the placing of a legend on my certificate for the Shares referring to such restriction and the placing of stop transfer orders until the Shares may be
transferred in accordance with the terms of such restrictions. 
 I have considered the Federal, state and local income tax
implications of the exercise of my Option and the purchase and subsequent sale of the Shares. 
 I am paying the option exercise
price for the Shares as follows: 
  

					
		  	  
	  	

 Please issue the stock certificate for the Shares (check one): 

 ̈ to me; or 

 ̈ to me and             , as
joint tenants with right of survivorship 
 and mail the certificate to me at the following address: 

 

					
		  	  
	  	
		  	  
	  	
		  	  
	  	

 My mailing address for shareholder communications, if different from the address listed above is:

  

					
		  	  
	  	
		  	  
	  	
		  	  
	  	

  

 A-2 

	
	Very truly yours,
	
	  

	Participant (signature)
	
	  

	Print Name
	
	  

	Date
	
	  

	Social Security Number

  

 A-3 

 Exhibit A 

NOTICE OF EXERCISE OF NON-QUALIFIED STOCK OPTION 

[Form For Registered Shares] 

TO: Neogenix Oncology, Inc. 
 IMPORTANT NOTICE:
This form of Notice of Exercise may only be used at such time as the Company has filed a Registration Statement with the Securities and Exchange Commission under which the issuance of the Shares for which this exercise is being made is registered
and such Registration Statement remains effective. 
 Ladies and Gentlemen: 

I hereby exercise my Non-Qualified Stock Option to purchase             
shares (the “Shares”) of the common stock, $0.00001 par value, of Neogenix Oncology, Inc. (the “Company”), at the exercise price of $             per share, pursuant to
and subject to the terms of that certain Non-Qualified Stock Option Agreement between the undersigned and the Company dated             , 20        .

 I understand the nature of the investment I am making and the financial risks thereof. I am aware that it is my
responsibility to have consulted with competent tax and legal advisors about the relevant national, state and local income tax and securities laws affecting the exercise of the Option and the purchase and subsequent sale of the Shares. 

I am paying the option exercise price for the Shares as follows: 

 

					
		  	  
	  	

 Please issue the Shares (check one): 

 ̈ to me; or 

 ̈ to me and             , as
joint tenants with right of survivorship, 
 at the following address: 

 

					
		  	  
	  	
		  	  
	  	
		  	  
	  	

  

 A-4 

 My mailing address for shareholder communications, if different from the address listed
above, is: 
  

					
		  	  
	  	
		  	  
	  	
		  	  
	  	

  

	
	Very truly yours,
	
	  

	Participant (signature)
	
	  

	Print Name
	
	  

	Date
	
	  

	Social Security Number

  

 A-5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00172-of-00352.parquet"}]]